Neurones (NRO) Q2 2025 TU earnings summary

Executive summary

• Organic growth reached 5.3% in Q2 2025 despite a more challenging economic environment.

• Notable growth areas included Data, Digital projects, market finance, ITSM solutions, and Business Process Management, with increased use of AI.

Financial highlights

• Q2 2025 revenues rose to €210.2M, up 6.4% year-over-year; organic growth was 5.3%.

• H1 2025 revenues totaled €424.3M, a 5.4% increase year-over-year; organic growth was 4.6%.

• Q1 2025 revenues were €214.1M, up 4.5% year-over-year; organic growth was 3.9%.

Outlook and guidance

• Full-year revenue forecast raised to approximately €850M.

• Operating profit margin guidance adjusted to around 8% for the year, with action plans in place.